We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+1.75%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$288M
AUM Growth
-$16.7M
Cap. Flow
-$20.4M
Cap. Flow %
-7.08%
Top 10 Hldgs %
36.94%
Holding
381
New
20
Increased
53
Reduced
63
Closed
59
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSC icon
201
Norfolk Southern
NSC
$78.3B
$30K 0.01%
200
COST icon
202
Costco
COST
$419B
$29K 0.01%
140
UNP icon
203
Union Pacific
UNP
$183B
$28K 0.01%
200
V icon
204
Visa
V
$712B
$28K 0.01%
210
LLY icon
205
Eli Lilly
LLY
$1.05T
$26K 0.01%
300
SDY icon
206
State Street SPDR S&P Dividend ETF
SDY
$22B
$26K 0.01%
280
SJM icon
207
J.M. Smucker
SJM
$14.1B
$26K 0.01%
238
WMT icon
208
Walmart Inc
WMT
$820B
$26K 0.01%
900
DOC icon
209
Healthpeak Properties
DOC
$14.5B
$25K 0.01%
966
BMS
210
DELISTED
Bemis
BMS
$25K 0.01%
600
BDX icon
211
Becton Dickinson
BDX
$51.6B
$24K 0.01%
104
BIDU icon
212
Baidu
BIDU
$32.9B
$24K 0.01%
100
D icon
213
Dominion Energy
D
$57.7B
$24K 0.01%
348
FMAT icon
214
Fidelity MSCI Materials Index ETF
FMAT
$622M
$24K 0.01%
700
+200
+40% +$6.8K
MCHP icon
215
Microchip Technology
MCHP
$39.6B
$24K 0.01%
538
SBUX icon
216
Starbucks
SBUX
$123B
$24K 0.01%
500
CALM icon
217
Cal-Maine
CALM
$3.75B
$23K 0.01%
500
RY icon
218
Royal Bank of Canada
RY
$283B
$23K 0.01%
300
CMD
219
DELISTED
Cantel Medical Corporation
CMD
$23K 0.01%
230
GSK icon
220
GSK
GSK
$102B
$22K 0.01%
440
LMT icon
221
Lockheed Martin
LMT
$130B
$22K 0.01%
+75
New +$24.2K
MET icon
222
MetLife
MET
$61.3B
$22K 0.01%
500
NOC icon
223
Northrop Grumman
NOC
$77.5B
$22K 0.01%
70
AIN icon
224
Albany International
AIN
$1.66B
$21K 0.01%
350
NLY icon
225
Annaly Capital Management
NLY
$17.4B
$21K 0.01%
500

Similar funds

American Research & Management Company's Q2 2018 Portfolio in Review

As of Q2 2018, American Research & Management Company held 381 positions worth $288M, down 5.5% from $305M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

American Research & Management Company withdrew a net $20.4M in Q2 2018, closing 59 positions and reducing 63 holdings. Its most notable exit was Wells Fargo & Company, an estimated $3.83M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, American Research & Management Company opened a new position in Procter & Gamble worth $5.7M.

  • American Research & Management Company's largest Q2 2018 buy was Procter & Gamble: 73,027 shares worth $5.7M.
  • American Research & Management Company added most to PepsiCo in Q2 2018, an estimated $1.39M increase.
  • American Research & Management Company's biggest Q2 2018 reduction was Dover, cutting an estimated $1.43M.
  • American Research & Management Company fully exited Wells Fargo & Company in Q2 2018, selling an estimated $3.83M.
  • American Research & Management Company's ten largest holdings make up 37% of its $288M portfolio in Q2 2018.
  • American Research & Management Company opened 20 new positions and closed 59 in Q2 2018.
  • American Research & Management Company's portfolio value fell 5.5% quarter-over-quarter to $288M.

Based on American Research & Management Company's 13F filing for Q2 2018, filed 25 Jul 2018.